Jacques Chapiro

1.6k citations

12 papers · 1.3k indexed · h-index 10

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 5%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Immunology 10
- Immunotherapy and Immune Responses 10
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 2
Molecular Biology 9
- Ubiquitin and proteasome pathways 6
- vaccines and immunoinformatics approaches 5
- Glycosylation and Glycoproteins Research 2

Co-authors: Benoı̂t J. Van den Eynde (9 shared papers)Vincent Stroobant (8 shared papers)Thierry Boon (7 shared papers)Pierre van der Bruggen (3 shared papers)Sandra Morel (4 shared papers)Erwin Schultz (2 shared papers)Benoît Guillaume (3 shared papers)Didier Colau (4 shared papers)
Journals: The Journal of Immunology (2 papers)Proceedings of the National Academy of Sciences (1 paper)Science (1 paper)Nature Immunology (1 paper)Cancer Immunology Immunotherapy (1 paper)
Partner nations: Belgium France United States

In The Last Decade

Jacques Chapiro

10 papers receiving 1.3k citations

Peers

Countries citing papers authored by Jacques Chapiro

Since Specialization

Citations

This map shows the geographic impact of Jacques Chapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Chapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Chapiro more than expected).

Fields of papers citing papers by Jacques Chapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Chapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Chapiro. The network helps show where Jacques Chapiro may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacques Chapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacques Chapiro Line = papers co-authored together Jacques Chapiro links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Tumor‐specific shared antigenic peptides recognized by human T cells Immunological Reviews ·Pierre van der Bruggen, Yi Zhang, Pascal Chaux, Vincent Stroobant, Christophe Panichelli, Erwin Schultz, Jacques Chapiro, Benoı̂t J. Van den Eynde, Francis Brasseur, Thierry Boon	2002	311
2	An Antigenic Peptide Produced by Peptide Splicing in the Proteasome Science ·Nathalie Vigneron, Vincent Stroobant, Jacques Chapiro, Annie Ooms, Gérard Degiovanni, Sandra Morel, Pierre van der Bruggen, Thierry Boon, Benoı̂t J. Van den Eynde	2004	262
3	Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules Proceedings of the National Academy of Sciences ·Benoît Guillaume, Jacques Chapiro, Vincent Stroobant, Didier Colau, Benoît Van Holle, Grégory K. Parvizi, Marie‐Pierre Bousquet, Ivan Théate, Nicolas Parmentier, Benoı̂t J. Van den Eynde	2010	180
4	Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases Cancer Research ·Véronique Corbière, Jacques Chapiro, Vincent Stroobant, Wenbin Ma, Christophe Lurquin, Bernard Lethé, Nicolas van Baren, Benoı̂t J. Van den Eynde, Thierry Boon, Pierre G. Coulie	2011	142
5	Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation The Journal of Immunology ·Jacques Chapiro, Stéphane Claverol, Fanny Piette, Wenbin Ma, Vincent Stroobant, Benoît Guillaume, Jean-Edouard Gairin, Sandra Morel, Odile Burlet‐Schiltz, Bernard Monsarrat, Thierry Boon, Benoı̂t J. Van den Eynde	2006	125
6	The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome The Journal of Experimental Medicine ·Erwin Schultz, Jacques Chapiro, Christophe Lurquin, Stéphane Claverol, Odile Burlet‐Schiltz, Guy Warnier, Vincenzo Russo, Sandra Morel, Frédéric Lévy, Thierry Boon, Benoı̂t J. Van den Eynde, Pierre van der Bruggen	2002	99
7	Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes The Journal of Immunology ·Benoît Guillaume, Vincent Stroobant, Marie‐Pierre Bousquet, Didier Colau, Jacques Chapiro, Nicolas Parmentier, Alexandre Dalet, Benoı̂t J. Van den Eynde	2012	67
8	Production of an antigenic peptide by insulin-degrading enzyme Nature Immunology ·Nicolas Parmentier, Vincent Stroobant, Didier Colau, Philippe de Diesbach, Sandra Morel, Jacques Chapiro, Peter Van Endert, Benoı̂t J. Van den Eynde	2010	53
9	A MAGE‐C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy International Journal of Cancer ·Wenbin Ma, Nathalie Vigneron, Jacques Chapiro, Vincent Stroobant, Catherine Germeau, Thierry Boon, Pierre G. Coulie, Benoı̂t J. Van den Eynde	2011	35
10	Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules Cancer Immunology Immunotherapy ·Tomoko So, Takeshi Hanagiri, Jacques Chapiro, Didier Colau, Francis Brasseur, Kosei Yasumoto, Thierry Boon, Pierre G. Coulie	2006	12
11	Une alpha thalassémie acquise chez un patient de 86 ans avec un syndrome myélodysplasique La Revue de Médecine Interne ·D. Cortese, Carmen Martínez, A. Dindoyal, Isabelle Alamome, R. Dragan, Jacques Chapiro, (unknown), O. Hinschberger	2023	0
12	Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial Annals of Oncology ·Michail Ignatiadis, Mariana Brandão, Marion Maetens, Noam Pondé, Samuel Martel, Stylianos Drisis, Isabelle Veys, S Mazy, E. Bollue, Patrick Neven, François P. Duhoux, Jacques Chapiro, Ahmad Awada, Tatiana Besse‐Hammer, Marianne Paesmans, Martine Piccart, Peter Vuylsteke, Christos Sotiriou	2018	0

About Jacques Chapiro

Jacques Chapiro is a scholar working on Immunology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Ubiquitin and proteasome pathways (6 papers), vaccines and immunoinformatics approaches (5 papers), T-cell and B-cell Immunology (3 papers), Glycosylation and Glycoproteins Research (2 papers), Immune Cell Function and Interaction (2 papers), CAR-T cell therapy research (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Immunology (915 citations), Oncology (533 citations), Molecular Biology (826 citations), Radiology, Nuclear Medicine and Imaging (110 citations) and Cell Biology (62 citations). Jacques Chapiro has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Benoı̂t J. Van den Eynde, Vincent Stroobant, Thierry Boon, Pierre van der Bruggen, Sandra Morel, Erwin Schultz, Benoît Guillaume, Didier Colau, Nathalie Vigneron and Nicolas Parmentier. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, Science, Nature Immunology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact